全球糖尿病监测设备市场

预计到 2030 年全球糖尿病监测设备市场规模将达 175 亿美元

全球糖尿病监测设备市场规模预计在2024年为121亿美元，到2030年将达到175亿美元，在2024-2030年的分析期间内，复合年增长率为6.4%。自我血糖监测设备是本报告分析的细分市场之一，预计其复合年增长率为5.2%，到分析期结束时规模将达到110亿美元。持续血糖监测设备细分市场在分析期间的复合年增长率预计为8.7%。

美国市场规模将达 33 亿美元；中国市场复合年增长率将达 9.8%

美国糖尿病监测设备市场规模预计2024年达到33亿美元。作为世界第二大经济体，中国市场规模预计将在2030年达到36亿美元，在分析期间（2024-2030年）的复合年增长率为9.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.2%和6.2%。在欧洲，德国的复合年增长率预计为4.2%。

全球糖尿病监测设备市场－主要趋势与驱动因素摘要

为什么糖尿病监测设备在现代疾病管理中很重要？

糖尿病是全球最常见的慢性疾病之一，糖尿病监测设备已成为管理糖尿病的关键，它能为患者和医护人员提供即时血糖值信息，并帮助他们更好地制定治疗方案。糖尿病影响全球超过5亿人，由于久坐不动的生活方式、不良饮食习惯和人口老化，预计患病人数还会迅速增加，因此对精准、便捷、持续血糖监测的需求比以往任何时候都更加迫切。这些设备透过维持血糖控制，在预防心血管疾病、神经病变、肾衰竭和视力丧失等併发症方面发挥关键作用。虽然血糖仪 (BGM) 等传统设备因其价格实惠、操作简便而仍然被广泛使用，但持续血糖监测 (CGM) 系统和闪光血糖监测仪正逐渐获得优势，因为它们无需扎手指即可提供每分钟的血糖更新。透过整合蓝牙和无线连接，这些工具正在转型成为智慧型设备，可与应用程式同步、支援云端资料储存并提供即时警报，从而赋予患者更大的自主权。此外，随着医疗保健系统越来越关注家庭慢性病管理，糖尿病监测设备对于个人护理和更广泛的公共卫生结果都变得至关重要。

科技如何彻底改变糖尿病监测设备的功能？

技术创新正在再形成糖尿病监测格局，推动设备准确性、易用性以及与整体数位健康生态系统的融合。如今，连续血糖监测仪 (CGM) 可提供长达两週的传感器佩戴、即时追踪和预测警报，以警告即将发生的低血糖或高血糖事件。生物感测材料和酵素技术的进步正在提高读数的准确性，同时最大限度地减少皮肤刺激和校准需求。穿戴式装置正变得越来越小、越来越隐密、越来越非侵入性，并且正在研究使用红外光谱和汗液分析进行无针血糖监测。智慧型手机整合允许用户记录饮食、药物和运动情况以及血糖读数，人工智慧主导的平台可以分析这些变数以提供个人化建议。云端基础的平台促进了与临床医生的数据共用，从而实现远端监测、早期疗育和减少就诊次数。闭合迴路胰岛素输送系统（也称为人工胰臟技术）将胰岛素帮浦与 CGM 结合，可根据即时血糖数据自动输送胰岛素。这些技术创新不仅提升了便利性和舒适性，也显着改善了第1型和第2型糖尿病患者的治疗效果。随着数位健康与穿戴式装置的融合，糖尿病监测正在演变成一种智慧、预测性和互联互通的照护模式。

为什么患者赋权和生活方式融合将推动设备的采用？

以患者为中心的照护和以生活方式为基础的疾病管理模式的转变是推动先进糖尿病监测设备普及的主要驱动力。现代患者不再是照护的被动接受者，而是积极的参与者，他们期望工具能够无缝融入日常生活，同时提供清晰的见解和可操作的数据。能够轻鬆融入日常生活的设备，例如可与智慧型手錶和健身追踪器通讯的动态血糖监测 (CGM)，正日益受到青睐，尤其是在科技达人和年轻群体中。即时血糖数据的心理影响也能鼓励人们坚持饮食建议、运动习惯和用药计画。对于运动员、忙碌的专业人士以及照顾糖尿病儿童的看护者来说，远端警报和趋势图等功能可以让他们安心，并增强对病情的管理。许多此类设备现在支援多语言介面、语音助理和教育功能，以促进对疾病机制和自我护理实践的理解。便捷且价格合理的设备正在被引入，以改善医疗资源匮乏人口的医疗服务可近性和健康公平性。随着糖尿病认知度的提高和耻辱感的减少，监测设备越来越多地被视为日常健康伙伴，而非临床工具。这种观念的转变正在鼓励人们更参与并长期坚持，而这正是成功控制血糖和减轻糖尿病相关併发症整体负担的关键因素。

推动全球糖尿病监测设备市场成长的关键因素有哪些？

糖尿病监测设备市场的成长受到人口、技术、政策和行为等多种因素的共同驱动，这些因素共同推动了人们对更精准的疾病追踪和个人化照护的重视。全球糖尿病盛行率的上升是主要驱动因素，尤其是在新兴国家，都市化、加工食品消费和遗传因素导致新增确诊病例激增。同时，已开发国家正经历人口老化，这增加了对慢性病管理工具的需求。政府倡议和医疗改革透过补贴血糖监测设备、扩大报销范围和开展公众意识宣传活动发挥支持作用。疫情加速了人们对预防保健和远端监测的重视，使穿戴式血糖监测仪成为虚拟护理策略的核心。科技公司和医疗保健提供者之间的伙伴关係也正在建立一个更一体化的生态系统，将穿戴式装置、电子健康记录 (EHR) 和人工智慧 (AI) 分析相结合，以实现全面的糖尿病管理。消费者对微创和用户友善设备的偏好正在影响研发工作，并推动製造商在设计和功能方面进行创新。此外，主要产业参与者向亚太地区、拉丁美洲和中东地区的战略扩张正在为其成长铺平新的道路。随着技术的成熟和全球健康重点转向主动护理，糖尿病监测设备有望成为管理这种普遍疾病的基础工具。

部分

产品类型（自我监测、持续血糖监测）；适应症（1 型糖尿病、2 型糖尿病、妊娠糖尿病）；最终用户（医院、诊所、居家医疗机构、其他最终用户）

受访公司范例（总合42家公司）

• Abbott Laboratories
• AgaMatrix
• Arkray, Inc.
• Ascensia Diabetes Care
• B. Braun Melsungen AG
• Bayer AG
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• i-SENS, Inc.
• Johnson & Johnson Services, Inc.
• LifeScan, Inc.
• Medtronic plc
• Novo Nordisk A/S
• Roche Diabetes Care
• Sanofi
• Senseonics Holdings, Inc.
• Tandem Diabetes Care, Inc.
• Valeritas Holdings, Inc.
• Ypsomed Holding AG

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Diabetes Monitoring Devices Market to Reach US$17.5 Billion by 2030

The global market for Diabetes Monitoring Devices estimated at US$12.1 Billion in the year 2024, is expected to reach US$17.5 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Self-Monitoring Blood Glucose Devices, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.0 Billion by the end of the analysis period. Growth in the Continuous Glucose Monitoring Devices segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 9.8% CAGR

The Diabetes Monitoring Devices market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Diabetes Monitoring Devices Market - Key Trends & Drivers Summarized

Why Are Diabetes Monitoring Devices Crucial in Modern Disease Management?

Diabetes monitoring devices have become indispensable in the management of one of the world’s most prevalent chronic diseases, offering patients and healthcare providers real-time insights into blood glucose levels and enabling better decision-making in treatment plans. With diabetes affecting over 500 million people globally and projections indicating a rapid rise due to sedentary lifestyles, poor dietary habits, and aging populations, the need for precise, accessible, and continuous glucose monitoring has never been greater. These devices play a pivotal role in preventing complications such as cardiovascular disease, neuropathy, kidney failure, and vision loss by helping maintain glycemic control. Traditional devices like blood glucose meters (BGMs) remain widely used for their affordability and simplicity, but continuous glucose monitoring (CGM) systems and flash glucose monitors are gaining dominance for their ability to provide minute-by-minute updates without the need for finger pricks. The integration of Bluetooth and wireless connectivity has transformed these tools into smart devices that sync with apps, allow for cloud data storage, and offer real-time alerts, empowering patients with greater autonomy. Additionally, healthcare systems are increasingly emphasizing home-based chronic disease management, making diabetes monitoring devices essential to both individual care and broader public health outcomes.

How Is Technology Revolutionizing the Functionality of Diabetes Monitoring Devices?

Technological innovation is reshaping the diabetes monitoring landscape, driving improvements in device accuracy, usability, and integration into holistic digital health ecosystems. Continuous glucose monitors (CGMs) now offer sensor wear times of up to two weeks, with real-time tracking and predictive alerts that warn of impending hypo- or hyperglycemic events. Advances in biosensing materials and enzymatic technology have increased the precision of readings while minimizing skin irritation and calibration needs. Wearable devices are becoming smaller, more discreet, and non-invasive, with research underway for needle-free glucose monitoring using infrared spectroscopy and sweat analysis. Smartphone integration enables users to log meals, medications, and exercise alongside glucose readings, while AI-driven platforms analyze these variables to deliver personalized recommendations. Cloud-based platforms facilitate data sharing with clinicians, allowing for remote monitoring, early intervention, and reduced in-person visits-an advantage magnified during the COVID-19 pandemic. Closed-loop insulin delivery systems, often referred to as artificial pancreas technologies, are combining insulin pumps and CGMs to automate insulin delivery based on real-time glucose data. These innovations are not just enhancing convenience and comfort but are also dramatically improving outcomes for both type 1 and type 2 diabetes patients. As digital health and wearables converge, diabetes monitoring is evolving into a smart, predictive, and connected care paradigm.

Why Is Patient Empowerment and Lifestyle Integration Driving Device Adoption?

The shift toward patient-centered care and lifestyle-based disease management is significantly boosting the adoption of advanced diabetes monitoring devices. Modern patients are no longer passive recipients of care but active participants who expect tools that fit seamlessly into their daily lives while offering clear insights and actionable data. Devices that integrate easily into routine activities-like CGMs that communicate with smartwatches or fitness trackers-are gaining favor, particularly among tech-savvy users and younger demographics. The psychological impact of real-time glucose data also encourages better adherence to dietary recommendations, exercise routines, and medication schedules. For athletes, busy professionals, or caregivers managing children with diabetes, features like remote alerts and trend graphs provide peace of mind and enhanced situational control. Many of these devices now support multilingual interfaces, voice assistants, and educational features that promote understanding of disease mechanics and self-care practices. In underserved populations, simplified and affordable models are being introduced to improve access and health equity. As awareness of diabetes grows and stigma decreases, monitoring devices are increasingly viewed not as clinical tools but as everyday wellness companions. This shift in perception is fostering higher engagement and long-term commitment, critical factors in achieving successful glycemic control and reducing the overall burden of diabetes-related complications.

What Are the Key Drivers Powering Global Growth in the Diabetes Monitoring Devices Market?

The growth in the diabetes monitoring devices market is driven by a confluence of demographic, technological, policy, and behavioral factors that collectively emphasize better disease tracking and personalized care. A major driver is the escalating global prevalence of diabetes, particularly in emerging economies where urbanization, processed food consumption, and genetic predispositions are fueling a surge in new diagnoses. Simultaneously, aging populations in developed nations are contributing to increased demand for chronic disease management tools. Government initiatives and healthcare reforms are playing a supportive role by subsidizing glucose monitoring devices, expanding reimbursement coverage, and launching public awareness campaigns. The growing emphasis on preventive healthcare and remote monitoring-accelerated by the pandemic-has placed wearable glucose monitors at the center of virtual care strategies. Partnerships between tech companies and healthcare providers are also creating more integrated ecosystems, combining wearables, EHRs, and AI analytics for comprehensive diabetes management. Consumer preference for minimally invasive and user-friendly devices is shaping R&D efforts, pushing manufacturers toward innovation in design and functionality. Furthermore, strategic expansion by key industry players into Asia-Pacific, Latin America, and the Middle East is opening new growth avenues. As technology matures and global health priorities shift toward proactive care, diabetes monitoring devices are set to become foundational tools in managing this pervasive disease.

SCOPE OF STUDY:

The report analyzes the Diabetes Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices); Indication (Type-I Diabetes, Type-II Diabetes, Gestational Diabetes); End-User (Hospitals, Clinics, Home Care Settings, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AgaMatrix
• Arkray, Inc.
• Ascensia Diabetes Care
• B. Braun Melsungen AG
• Bayer AG
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• i-SENS, Inc.
• Johnson & Johnson Services, Inc.
• LifeScan, Inc.
• Medtronic plc
• Novo Nordisk A/S
• Roche Diabetes Care
• Sanofi
• Senseonics Holdings, Inc.
• Tandem Diabetes Care, Inc.
• Valeritas Holdings, Inc.
• Ypsomed Holding AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Diabetes Monitoring Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Global Diabetes Epidemic Throws the Spotlight on Continuous Glucose Monitoring (CGM) Systems
  • Shift Toward Non-Invasive Monitoring Technologies Fuels R&D in Next-Generation Sensor Innovation
  • Growth in Wearable and App-Based Glucose Trackers Accelerates Patient Engagement and Real-Time Monitoring
  • Rising Demand for Personalized Diabetes Management Strengthens Use of Integrated CGM-Insulin Delivery Systems
  • Push Toward Value-Based Care Models Supports Use of Remote Glucose Monitoring in Chronic Disease Programs
  • Expansion of Type 2 Diabetes Screening in Emerging Markets Increases Demand for Affordable Glucometers
  • Adoption of AI and Predictive Analytics in Glucose Data Supports Real-Time Hypo/Hyperglycemia Alerts
  • Growth of Pediatric Diabetes Management Drives Need for Child-Friendly, Low-Burden Monitoring Tools
  • Increased Use of CGM in Gestational Diabetes Management Expands Clinical Application Range
  • Integration with EHR and Telehealth Services Enables Endocrinologist-Patient Collaboration
  • Consumer Preference for Discreet, Pain-Free Devices Propels Innovation in Skin-Adhesive Patch Monitors
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Diabetes Monitoring Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Diabetes Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Self-Monitoring Blood Glucose Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Self-Monitoring Blood Glucose Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Self-Monitoring Blood Glucose Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Continuous Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Continuous Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Type-I Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Type-I Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Type-I Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Type-II Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Type-II Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Type-II Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Gestational Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Diabetes Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Diabetes Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Diabetes Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION